| scholarly article | Q13442814 |
| P50 | author | Ronit Katz | Q30437553 |
| David S Siscovick | Q86839898 | ||
| Joachim H. Ix | Q87220141 | ||
| Bryan R Kestenbaum | Q87223694 | ||
| Kenneth J. Mukamal | Q99254177 | ||
| P2093 | author name string | Ian H de Boer | |
| Linda F Fried | |||
| Carmen A Peralta | |||
| Michel B Chonchol | |||
| P2860 | cites work | Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD | Q24652643 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease | Q28257707 | ||
| Insulin degradation: progress and potential | Q28287093 | ||
| Evaluation of methods for the measurement of low-density lipoprotein cholesterol. | Q29547378 | ||
| The Cardiovascular Health Study: design and rationale | Q29614874 | ||
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
| Physical activity and rapid decline in kidney function among older adults | Q33885961 | ||
| Standards of medical care in diabetes--2011. | Q34425055 | ||
| Cardiovascular complications in chronic kidney disease | Q35140917 | ||
| Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications | Q36492059 | ||
| Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity | Q36730493 | ||
| Insulin resistance in uremia | Q36995902 | ||
| Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey. | Q37279091 | ||
| The human glomerular podocyte is a novel target for insulin action | Q40357961 | ||
| Reduced time points to calculate the composite index | Q43001826 | ||
| Insulin resistance as a predictor of age-related diseases | Q43705609 | ||
| Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study | Q43747863 | ||
| Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death | Q44024465 | ||
| Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study | Q44043328 | ||
| Insulin resistance and risk of chronic kidney disease in nondiabetic US adults | Q44285460 | ||
| Cystatin C improves the detection of mild renal dysfunction in older patients | Q44663240 | ||
| Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp | Q46415645 | ||
| Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study | Q46774747 | ||
| Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study | Q46856822 | ||
| Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. | Q50981261 | ||
| Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. | Q51557740 | ||
| Hyperinsulinemia as an independent risk factor for ischemic heart disease. | Q51581884 | ||
| Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland | Q51662797 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations | Q66980021 | ||
| Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study | Q70785076 | ||
| Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine | Q72192988 | ||
| Insulin induces a change in extracellular matrix glycoproteins synthesized by rat mesangial cells in culture | Q72898066 | ||
| Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment | Q73938868 | ||
| High glucose, high insulin, and their combination rapidly induce laminin-beta1 synthesis by regulation of mRNA translation in renal epithelial cells | Q79678248 | ||
| Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study | Q79678578 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| P304 | page(s) | 1355-1360 | |
| P577 | publication date | 2012-03-19 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Insulin resistance, cystatin C, and mortality among older adults | |
| P478 | volume | 35 |
| Q37682226 | Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4. |
| Q51257461 | Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis. |
| Q37389298 | Impact of Growth Hormone on Cystatin C. |
| Q64264442 | Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study |
| Q34145851 | Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults. |
| Q38587721 | Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions |
| Q42380185 | Insulin resistance in CKD. |
| Q49859006 | Insulin resistance in chronic kidney disease |
| Q33992726 | Insulin resistance in chronic kidney disease: a step closer to effective evaluation and treatment |
| Q30244271 | Insulin resistance in chronic kidney disease: a systematic review |
| Q36874538 | Nighttime BP in Elderly Individuals with Prediabetes/Diabetes with and without CKD: The HEIJO-KYO Study |
| Q90248138 | Non-invasive Quantification of Fat Deposits in Skeletal Muscle Predicts Cardiovascular Outcome in Kidney Failure |
| Q38579223 | Plasticity of circadian clocks and consequences for metabolism |
| Q53832341 | Reducing insulin resistance in patients undergoing peritoneal dialysis through the use of icodextrin-based solutions. |
| Q38371171 | The Western Diet and Chronic Kidney Disease |
| Q51327721 | Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function. |
| Q37330255 | Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial |
Search more.